Home
TVRD
TVRD Forecast

TVRD

Tvardi Therapeutics Inc. Common Stock

as 06-18-2025 4:00pm EST

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

More About Our TVRD ML Model...

What kind of parameters do you use to train TVRD stocks ML model?

To train our stocks TVRD ML model, we use historical data with over 25 parameters, including volume indicators, volatility indicators, momentum indicators, trend indicators, and other metrics.

How often do you update TVRD ML model?

We update our ML model either weekly or biweekly, depending on the market capitalization of the stocks, using TensorFlow, typically over the weekend.

Why is the accuracy of your TVRD model low?

Unfortunately, our current data provider offers limited historical data, which impacts the accuracy of our ML model. However, as we continue to gather more data over time and add more indicators, we expect the accuracy of our model to improve.

How can I provide and share more data with you to increase your ML model accuracy?

We would greatly appreciate your contribution. Please send an email to [email protected]

Do you offer an ML model for shorter time periods, such as 5 minutes or 15 minutes?

Yes, we offer it for strategy purposes only, with intervals: 1 minute, 2 minutes, 5 minutes, 15 minutes, and 30 minutes etc.

Can I rely on your ML model to make financial decisions regarding buying or selling stocks, or is it only intended for learning purposes?

Our ML model is primarily designed for educational purposes and is not intended to provide financial advice. We strongly recommend consulting with a financial advisor before making any buying or selling decisions.

Share on Social Networks:

Disclaimer

Our TVRD ML model is developed exclusively for educational purposes. Any information presented on this page regarding the '"TVRD Forecast & Prediction for June 19, 2025 Tvardi Therapeutics Inc. Common Stock" should not be considered as financial advice or as a recommendation to buy or sell stocks. It is provided strictly for educational purposes. Investing in stocks involves significant risks, and decisions should be made only after careful consideration and consultation with a qualified financial advisor.